Quantifying and combating zoonotic viruses poised for emergence: Using multiplex receptor screening and decoy engineering technologies
A new and unique paradigm shift toward proactive antiviral interventions centered on host-identified multivalent “decoy” receptor therapeutics that can impose high evolutionary barriers to resistance, even in convergent evolution scenarios.
Oseltamivir aziridines are potent influenza neuraminidase inhibitors and imaging agents
The inhibitors demonstrate formidable activity against diverse viral neuraminidases, including H5N1, and further enable imaging and quantification of active NA.
|
10th ESWI Influenza Conference 2025
Optimising Antiviral Strategies for Respiratory Viruses
While a wide array of antiviral medications exists to combat respiratory viruses such as SARS-CoV-2, RSV and influenza, their individual effectiveness is often underexplored.
Antiviral use and the effects of drug resistance on the transmission dynamics of influenza
The effectiveness of antivirals in mitigating influenza outbreaks depends on both their ability to reduce the number of infections and the risk of drug resistance.
News
Policy & Recommendations
The European Commission proposes new rules to ensure stable supply of critical medicines
This initiative contributes to the European Health Union's goal of ensuring that EU patients have access to the medicines they need, when they need them.
Three new studies probe the efficacy of antivirals in preventing and treating influenza
Two find that the drugs may shorten hospital stays and decrease the risk of infection in those at high risk for severe illness, and one concludes that timely initiation reduces the risk of death from flu-related pneumonia.
When should you take antiviral drugs?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
News
Scientific Papers
Viral Times
|
9th Influenza Conference 2023
Scientific highlights of the 9th ESWI Influenza Conference
With promising developments in the field of respiratory viral infections, the conference sessions covered hot topics on seasonal, pandemic, and zoonotic influenza viruses, as well as other respiratory viruses such as RSV and SARS-CoV-2.
